Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $208.84 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TherapeuticsMD, Inc. | $121.85 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $28.37 | 2 | $0 (2022) |
| Amarin Pharma Inc. | $21.44 | 1 | $0 (2019) |
| Amgen Inc. | $13.57 | 1 | $0 (2018) |
| Lilly USA, LLC | $12.00 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $11.61 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $16.01 | 1 | AstraZeneca Pharmaceuticals LP ($16.01) |
| 2019 | $166.90 | 4 | TherapeuticsMD, Inc. ($121.85) |
| 2018 | $25.93 | 2 | Amgen Inc. ($13.57) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neuroscience | ||||||
| 09/18/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 09/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/17/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/14/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Neuroscience | ||||||
| 08/27/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. Nitin Hate, MD
Dr. Nitin Hate, MD is a Occupational Medicine healthcare provider based in Cape Canaveral, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013035070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nitin Hate, MD has received a total of $208.84 in payments from pharmaceutical and medical device companies, with $16.01 received in 2022. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($208.84).
Practice Information
- Specialty Occupational Medicine
- Location Cape Canaveral, FL
- Active Since 03/27/2007
- Last Updated 07/21/2022
- Taxonomy Code 2083X0100X
- Entity Type Individual
- NPI Number 1013035070
Products in Payments
- IMVEXXY (Drug) $121.85
- FARXIGA (Drug) $28.37
- Vascepa (Drug) $21.44
- Aimovig (Biological) $13.57
- EMGALITY (Drug) $12.00
- XARELTO (Drug) $11.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.